Neuralstem (CUR) Pops Higher as Traders Pass Around "Amazing Results" Article

December 3, 2012 2:28 PM EST
Shares of Neuralstem (NYSE: CUR) are seeing mid-day action with the move being attributed to an Crain's article dated November 30, 2012 making the rounds. The article discusses positive results from the company's stem-cell injections.

In addition, there is a stem cell conference ongoing in West Palm Beach, Florida.

Shares of CUR are up 7 percent mid-day to $1.34.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment